Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Phase 3:2
Drug Approvals
9
FDA:9
Drug Approvals
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate
- Approval Date
- Dec 26, 2019
FDA
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 3
2 (100.0%)A Study to Evaluate Safety and Efficacy Following Dosing of Oxycodone/Naltrexone for Treatment of Adults With Pain Following Bunionectomy Surgery
Phase 3
Completed
- Conditions
- Pain
- Interventions
- First Posted Date
- 2015-03-30
- Last Posted Date
- 2016-08-09
- Lead Sponsor
- Elite Laboratories, Inc
- Target Recruit Count
- 163
- Registration Number
- NCT02401750
- Locations
- 🇺🇸
Premier Research, Austin, Texas, United States
🇺🇸Chesapeake Research Group, Pasadena, Maryland, United States
🇺🇸Endeavor Clinial Trials, San Antonio, Texas, United States
A Study to Evaluate Withdrawal Effects Following Dosing of Oxycodone/Naltrexone in Methadone-Maintained Subjects
Phase 3
Completed
- Conditions
- Withdrawal Symptoms
- Interventions
- First Posted Date
- 2015-03-18
- Last Posted Date
- 2016-08-10
- Lead Sponsor
- Elite Laboratories, Inc
- Target Recruit Count
- 26
- Registration Number
- NCT02391571
- Locations
- 🇺🇸
Vince and Associates, Overland Park, Kansas, United States
News
No news found